| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/04/2002 | CN1366957A Nano Bawei Shenqi preparation medicine and preparation method |
| 09/04/2002 | CN1366955A Nano ass hide glue preparation medicine and preparation method |
| 09/04/2002 | CN1366940A Nano indigo and clamshell preparation medicine and preparation method |
| 09/04/2002 | CN1366890A Nano clear heat and resolve toxin preparation medicine and preparation method thereof |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444824 Antiserotonine agents; side effect reduction |
| 09/03/2002 | US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444789 CD16-II variants |
| 09/03/2002 | US6444700 Nutrient mixture of vitamin c and e, beta-carotene, selenium and glyceride |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444663 Treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury. |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/03/2002 | CA2128293C Fruit polyphenols and medicinal compositions containing them |
| 09/03/2002 | CA1341387C Human manganese superoxide dismutase (hmn-sod) |
| 08/29/2002 | WO2002066649A2 ANTI-INTERFERON-α ANTIBODIES |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 08/29/2002 | WO2002066602A2 Detection of allergen-specific ige |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066481A1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 08/29/2002 | WO2002066476A1 6-phenylbenzonaphthyridines |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066460A1 Chemical compounds |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066429A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby |
| 08/29/2002 | WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | WO2002066420A2 Tryptase inhibitors |
| 08/29/2002 | WO2002066059A2 Agents that specifically block cd28-mediated signaling and uses therefor |
| 08/29/2002 | WO2002066057A2 Methods and compositions for preventing and treating neutrophil-mediated diseases |
| 08/29/2002 | WO2002066056A2 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | WO2002066055A1 NOVEL MEDICINAL USE OF α ANTIGEN OR α ANTIGEN GENE |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066045A2 Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a |
| 08/29/2002 | WO2002065985A2 Methods of treating diabetes mellitus |
| 08/29/2002 | WO2002050108A3 Immunogenic glycopeptides, screening, preparation and uses |
| 08/29/2002 | WO2002043649A3 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 08/29/2002 | WO2002042316A3 Pna analogues |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002037937A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002028867A3 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002016409A3 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2002002141A3 Vaccine against helicobacter pylori |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001085154A3 Method of treating immune pathologies with low dose estrogen |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001071342A3 Identification of mast cell/basophil activation inhibitors |
| 08/29/2002 | WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2001005792A9 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 08/29/2002 | WO2000010981A9 Quinazoline derivatives |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120141 Dye labeled imidazoquinoline compounds |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119976 Tetracyclic derivatives, process of preparation and use |
| 08/29/2002 | US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119963 Fertility; antidiabetic agents |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119946 Formative agent of protein complex |
| 08/29/2002 | US20020119932 RGD-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | US20020119571 Stimulating lymphocytes of graft recipient by cells of graft donor or by cells expressing dominant Major Histocompatability Complex-molecules while transduced with immunmodulatory genes using gene transfer; prevents rejection of allogeneic grafts |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 08/29/2002 | US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions |
| 08/29/2002 | US20020119190 Oil-free pharmaceutical compositions containing cyclosporin A |
| 08/29/2002 | US20020119164 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 08/29/2002 | US20020119159 Administering to a mucosal surface inducing antigen and mucosal binding component in unconjugated form for inducing sustained immunological tolerance in an individual to a target antigen |
| 08/29/2002 | US20020119151 CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/29/2002 | US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft |
| 08/29/2002 | US20020119147 Apparatus for enhancing immune responses in mammals |